-
Mashup Score: 1The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus? - World Journal of Urology - 1 year(s) ago
Purpose Stereotactic body radiotherapy (SBRT) is an emerging treatment option for localized prostate cancer. There is increasing interest to reduce the number of fractions for prostate SBRT. Methods We provide a narrative review and summary of prospective trials of different fractionation schedules for prostate SBRT, focusing on efficacy, toxicities, and quality of life outcomes. Results There…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Among patients with Gleason score 9-10 prostate cancer, treatment with EBRT+BT with androgen deprivation therapy was associated with significantly better prostate cancer-specific mortality and longer time to distant metastasis compared with EBRT with androgen deprivation therapy or with RP.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
I think we should have a virtual debate between @dr_coops and @AmarUKishan. How do we square this study with the two individual pt data centres of excellence study that @AmarUKishan published that show the opposite results?!? https://t.co/dXJMJFSKcw https://t.co/GfwgkfFnuR https://t.co/34sMTgoD6p
-
-
Mashup Score: 5
External beam radiotherapy (EBRT) is a curative treatment for Localized Prostate Cancer (LPCa). Large randomized controlled trials (RCTs) have shown moderately hypo fractionated regimens (2.5 – 3 Gy/fraction(f)) as non-inferior to 2Gy/f regimens. PACE-B aims to demonstrate non-inferiority of SBRT compared to conventionally or moderately hypo fractionated regimens for biochemical and/or clinical failure (BCF).
Source: www.redjournal.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @SRS_SBRT_SG: https://t.co/lfEGPiv4e3 5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing (SB…
-
-
Mashup Score: 2Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and Opportunities - PubMed - 1 year(s) ago
Despite increasing utilization, many men do not receive multidisciplinary care prior to radical prostatectomy. While geography and the urologist appear to be the greatest factors predicting multidisciplinary care receipt, these factors are closely intertwined.
Source: pubmed.ncbi.nlm.nih.govCategories: Hem/Oncs, Latest HeadlinesTweet-
Not sure if “not receiving a multiD consult” was a predictor? < 50% of patients in Ontario (despite Rad Onc consult being tied to hospital funding for RP) get a consult (but that’s up from 20% so progress I guess?!?) Here’s the @DrMarkCorkum ref https://t.co/5q6QRHUc0k https://t.co/jClJoq3LQw
-
-
Mashup Score: 7Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer - 1 year(s) ago
There is no evidence-based data to guide dose constraints in two-fraction prostate stereotactic ablative radiotherapy (SABR). Using individual patient…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Here's the free link to @weeloonong dosimetric correlates of 2 fraction prostate SBRT published in @RadiotherapyOn1 https://t.co/CDNl8MnlXP https://t.co/KJ1bhinAsH
-
-
Mashup Score: 0I left the U.S. for Paris 12 years ago—6 things French people do differently than Americans to live long, happy lives - 2 year(s) ago
After moving from New York to Paris in 2011, Ajiri Aki discovered a new, more joyful perspective on life. Here’s what the mother and lifestyle guru learned from French people about how to live a long, happy life.
Source: CNBCCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @SimonLo21054188: I left the U.S. for Paris—6 things French people do differently to live long, happy lives https://t.co/xiynGG02aG
-
-
Mashup Score: 0
4yPSARR is an encouraging early predictor of outcome in patients with intermediate-risk PCa treated with SBRT. Validation in prospective trials is warranted.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
@sophia_kamran I continue to see PSAs continue to fall (albeit slightly) even 10y after #SBRT. I think PSARR@4y (<0.4) is best “early” marker See @r_glicksman Clin Oncol 2022 https://t.co/ucRzJ9RogI
-
-
Mashup Score: 1William Osler - Wikipedia - 2 year(s) ago
From Wikipedia, the free encyclopedia Sir William OslerBt FRS FRCPPhotograph of Osler, c. 1912BornJuly 12, 1849Bond Head, Province of CanadaDiedDecember 29, 1919 (aged 70)Oxford, EnglandNationalityCanadianAlma materTrinity College, TorontoMcGill University (MDCM)Known forco-founding physician of Johns Hopkins HospitalSpouseGrace Revere OslerChildren2 sonsScientific careerFieldsPhysician,…
Source: en.wikipedia.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Osler was Canadian. Just putting it out there… in case anyone from outside of Canada forgot. https://t.co/R4Ic26AKGf https://t.co/F9u6pFVSXN
-
-
Mashup Score: 0Our History - 2 year(s) ago
Dr. Gordon Richards. 1919 After World War 1, burgeoning knowledge in the medical uses of radiation led to the need to recognize radiology as a unique academic discipline…
Source: radonc.utoronto.caCategories: Hem/Oncs, Latest HeadlinesTweet-
Dr Peters and many other #RadOnc / #RadMed giants came from @uoftmedicine @UofTDRO Read the brief history here: https://t.co/NrjZ9ChJed https://t.co/lpksAldosZ
-
-
Mashup Score: 0
APP4 may be an easily accessible promising prognostic measure for patients with intermediate-risk prostate cancer treated with SBRT. Incorporation of APP4 into prospective trials will help to determine its value.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
Another way (if your pathologist reports % rather than length of involvement): APP4 = absolute percentage pattern 4/5 = % total surface area x %G4/5 Predicts bDFS and trend on MFS (just need more power) Here’s @r_glicksman citation: https://t.co/OoSo0PQjTn https://t.co/M5u4bjo0Sr
-
RT @weeloonong: @DrAndrewLoblaw link to the article https://t.co/bXq3XlEQyM